The Wall Street Journal: FDA, J&J set to announce Baltimore vaccine plant ready to reopen


The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce as early as Friday that contamination problems at a COVID-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

The Wall Street Journal: Google close to settling ad-tech antitrust case in France

Previous article

Outside the Box: Inflation in drug prices is soaring and it’s time to break Big Pharma’s grip on our health

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News